CIK 0001275187
- Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113146460
- Phone
- +1 518-798-1215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-26 | Simpson Robert Arthur SVP/GM, Global Vascular | Grant or award · Non-Qualified Stock Option (right to buy) | +13,137 | 13,137 | ||
| 2017-07-26 | Simpson Robert Arthur SVP/GM, Global Vascular | Grant or award · Performance Right | +7,477 | 7,477 | ||
| 2017-07-26 | Greiner Michael EVP and CFO | Grant or award | +6,193 | 16,193 | ||
| 2017-07-26 | Greiner Michael EVP and CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +21,762 | 21,762 | ||
| 2017-07-26 | Greiner Michael EVP and CFO | Grant or award · Performance Right | +12,387 | 12,387 | ||
| 2017-07-26 | Trowbridge Stephen A SVP and General Counsel | Grant or award | +3,705 | 34,947 | ||
| 2017-07-26 | Trowbridge Stephen A SVP and General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +13,018 | 13,018 | ||
| 2017-07-26 | Trowbridge Stephen A SVP and General Counsel | Grant or award · Performance Right | +7,409 | 7,409 | ||
| 2017-07-25 | JOHNSON WESLEY Director | Option exercise | +14,000 | $15.75 | $221K | 60,974 |
| 2017-07-25 | JOHNSON WESLEY Director | Shares withheld for taxes | −12,879 | $17.12 | $220K | 48,095 |
| 2017-07-25 | JOHNSON WESLEY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −14,000 | 0 | ||
| 2017-07-25 | Meteny Dennis S Director | Option exercise | +14,000 | $15.75 | $221K | 83,127 |
| 2017-07-25 | Meteny Dennis S Director | Shares withheld for taxes | −12,879 | $17.12 | $220K | 70,248 |
| 2017-07-25 | Meteny Dennis S Director | Option exercise · Non-Qualified Stock Option (right to buy) | −14,000 | 0 | ||
| 2017-07-25 | GOLD JEFFREY Director | Option exercise | +14,000 | $15.75 | $221K | 66,037 |
| 2017-07-25 | GOLD JEFFREY Director | Shares withheld for taxes | −12,879 | $17.12 | $220K | 53,158 |
| 2017-07-25 | GOLD JEFFREY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −14,000 | 0 | ||
| 2017-07-25 | Richard Stark SVP, GM - Oncology | Shares withheld for taxes | −432 | $17.12 | $7K | 17,608 |
| 2017-07-25 | Trowbridge Stephen A SVP and General Counsel | Shares withheld for taxes | −437 | $17.12 | $7K | 31,242 |
| 2017-07-24 | REED JAN STERN Director | Purchase | +316 | $16.00 | $5K | 316 |
Page 33 of 41 · 813 trades